Article Details
Retrieved on: 2021-08-10 21:32:31
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Law360 (August 10, 2021, 5:32 PM EDT) -- Clinical-stage biotechnology company Eliem Therapeutics priced an $80 million initial public offering and ...
Article found on: www.law360.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here